| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.2M | +53.4% |
| Cost of Revenue | $7.0M | +69.8% |
| Gross Profit | $38.2M | +50.8% |
| R&D Expense | $15.0M | -15.4% |
| SG&A Expense | $21.5M | +19.4% |
| Operating Income | -$26.9M | +25.5% |
| Pre-tax Income | -$39.2M | -30.6% |
| Income Tax | $7K | +16.7% |
| Net Income | -$39.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.4M | +139.8% |
| Accounts Receivable | $6.6M | +28.9% |
| Inventory | $3.1M | -24.0% |
| Current Assets | $32.2M | +56.0% |
| Total Assets | $35.3M | +47.4% |
| Current Liabilities | $11.5M | +12.4% |
| Long-term Debt | $33.0M | +49.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | +55.9% |
| Capital Expenditures | $918K | +166.1% |
| Investing Cash Flow | -$838K | -142.9% |
| Financing Cash Flow | $30.8M | -18.9% |
| Free Cash Flow | -$18.9M | +54.0% |
| -30.6% |
| EPS (Basic) | -$1.84 | -40.5% |
| EPS (Diluted) | -$1.84 | -40.5% |
| Total Liabilities |
| $69.2M |
| +38.8% |
| Stockholders' Equity | -$33.9M | -30.8% |